Time Horizon: 12-18 months. DEMAND-type thesis (365d half-life) with EXECUTION catalyst (180d half-life). Key resolution points: Q3 FY2026 earnings June 25, 2026 (margin inflection test), FY2026 10-K October 2026 (material weakness resolution, full-year ASV), AlphaSense IPO H2 2026/H1 2027 (narrative test).

B — Business Model

FactSet sells financial data, analytics, and workflow tools to the investment industry on annual subscriptions. $2.45B organic ASV, 9,101 clients, 241,352 users. Revenue is ratably recognized from contractual subscriptions — textbook recurring CF_t.

Revenue decomposition:

• Americas (66% of ASV): organic ASV +7.0%, the growth engine
• EMEA (24%): +4.3%, lagging and margin-negative
• Asia Pacific (10%): +10.0%, fastest but smallest

Unit economics: Revenue/client ≈$269K/yr. Revenue/user ≈$10.1K/yr. Dollar retention >95% for 3+ consecutive years. Average client relationship: 16 years. (10-Q Q2 FY2026, q=0.95.)

What it actually sells — five layers:

1. Data Engine (the moat). Concordance + entity resolution: 40 years of mapping every entity across hundreds of data sources into a unified model. Client data custody: 40% of ASV involves FDS holding and processing the client's OWN portfolio data — holdings, trades, benchmarks, analytical parameters. This isn't content licensing; it's a data custody arrangement. 8.4 billion FQL queries/day (≈35K per user, overwhelmingly automated). CEO first-ever disclosure: 90% of ASV is proprietary or enriched content, only 10% publicly accessible data. (Q1 FY2026 transcript, q=0.90.)

2. CUSIP Global Services (regulated monopoly). Net carrying value $1,407M (33% of total assets, 36-year useful life). Exclusive issuer of CUSIP/CINS identifiers globally. Official ISIN numbering agency for US + 30 countries. Every US security requires a CUSIP. Near-zero marginal cost, revenue scales with issuance activity. Acquired from S&P in 2022 for ≈$1.925B as a regulatory divestiture condition.

3. Delivery. Workstation, data feeds/APIs, cloud connectors, MCP servers (data delivery to AI agents — new, strategically important), LiquidityBook OMS/EMS (acquired Feb 2025), managed services. Open platform strategy vs Bloomberg's closed ecosystem.

4. Analytics. Portfolio analytics (Vault), risk management, reporting, compliance, wealth advisory (+30% seat growth FY2024). Research management is the ONE workflow where AlphaSense has genuine overlap (≈2 of 10 workflow categories).

5. AI (emerging). Mercury conversational agent, pitch creation, workflow automation (35% of formula support handled by AI agents), MCP data delivery. Chief AI Officer created March 2, 2026. 45% sequential AI product adoption growth. Multi-year 5-7 year renewals citing AI as key component. (Q1/Q2 FY2026 transcripts, q=0.90; 8-K Mar 4, 2026, q=0.95.)

Architecture verdict: Platform, not point solution. Spans full investment lifecycle. The moat is in the plumbing — concordance, client data custody, CUSIP monopoly, 8.4B daily query integrations — not in the terminal UX. AI needs clean, concorded financial data. FDS is where that data lives.

Phi — Financial Trajectory

Revenue (g = dR/dt): Accelerating

Organic ASV growth: +5.7% (FY2025) to +5.9% (Q1 FY2026) to +6.7% (Q2 FY2026) — three consecutive accelerations. H1 FY2026 reported revenue +7.0% ($1,218.6M). Users +10.1% to 241,352, clients +5.3% to 9,101. (10-Q Q2 FY2026, q=0.95.)

Margins (dm/dt): Compressing — FDS-specific

(10-K FY2025, 10-Q Q2 FY2026, q=0.95.)

FDS is the ONLY peer with margin compression. All 6 financial data peers are expanding 90-300bps: SPGI +50-75bps, MCO +280bps, RELX +90bps (5th consecutive year), MORN +210bps, TRI expanding. (Cross-ticker analysis from 10-Ks/10-Qs, q=0.90.)

Compression drivers:

Temporary (≈$20M H1, rolling off):

• CEO one-time make-whole awards: $10.6M H1 (employment agreement, q=0.95)
• India Labor Codes Reform: $2.9M Q2 (government regulation, one-time, q=0.95)
• Equity investment impairment: $10.2M Q2 (non-cash, q=0.95)

Structural (≈170bps of adjusted margin decline):

• Intangible amortization +20% YoY ($150M annualized, 6.1% of revenue heading to 6.5-7.0%)
• Cloud/AI infrastructure spend rising
• Compensation inflation (especially EMEA: annual merit increases in a 4% growth region)

The 10 details the synthesis glossed over:

1. Incremental margins are zero. H1 FY2026: $79.3M more revenue produced $205K more operating profit. Flow-through rate: 0.26%. Even adjusted: 17.3%. A subscription data business should deliver 50-70%. (10-Q segment tables, q=0.95.)

2. EMEA is hemorrhaging. Q2 incremental margin: -75.5%. Each $1 of new EMEA revenue costs $0.76 in operating profit. Attributed to "annual merit increases" — structural labor cost inflation, not investment spending. (10-Q MD&A, q=0.95.)

3. Americas H1 incremental margin is negative (-3.7%). Largest segment (66% of ASV) generated $59M more revenue and made $2.2M less profit. (10-Q, q=0.95.)

4. OpEx growing 1.5x revenue. Revenue +7.0%, CoS +10.7%, SG&A +9.8%, Total OpEx +10.4%. Negative operating leverage across every cost line. (10-Q, q=0.95.)

5. Management's own math has a shortfall. Guided 250bps investment offset by 100bps productivity = net 150bps pressure. Actual: 180bps adjusted. 30bps behind schedule. (Q4 FY2025 transcript vs 10-Q Q2 FY2026, q=0.85-0.95.)

6. MORN comparison. Similar revenue (≈$2.2B), similar model, similar AI investment cycle. MORN: margins +210bps. FDS: margins -180bps. Nearly 400bps divergence. (Cross-ticker 10-Ks, q=0.90.)

FCF: Solid but conversion declining

FCF ≈$600M annualized (6.6% yield at $8.4B market cap). FCF/NI declining from 1.25x (FY2023) to ≈1.0x (H1 FY2026), driven by rising capex. Funded entirely from operating cash flow — not drawing on the $1.0B undrawn revolver. (10-Q Q2 FY2026, q=0.95.)

Balance sheet: Clean

Net debt ≈$1.1B (1.2x trailing EBITDA). Interest coverage ≈18x. Nearest maturity: $500M at 2.9% in March 2027 — refinancing at ≈5.5% adds ≈$13M/year interest (≈2.3% earnings headwind). Goodwill + intangibles = 75.2% of total assets (CUSIP acquisition legacy). (10-Q Q2 FY2026, q=0.95.)

Capital allocation: Aggressive buyback

H1 FY2026 buybacks: $302.9M (2.68x vs H1 FY2025). Feb 2026: 298K shares at avg $207 (near 52-week low). $697M remaining authorization, no expiration. Funded from operating cash flow, not debt. Cross-ticker: 6/6 peers accelerating buybacks at AI-panic prices, $10B+ combined in 2025. (10-Q, cross-ticker 10-Ks/10-Qs, q=0.95.)

Buyback is 16% underwater. Average H1 purchase price: $268 vs current $225. 73% of dollars deployed before the AI-panic bottom. (10-Q, q=0.95.)

K — Competitive Position

Moat stack:

Switching cost phi = 0.70-0.85 overall. Top-25 AM: phi = 0.90 (switching cost $10-20M+, 12-18 month migration). Mid-size hedge fund: phi = 0.80 ($2-5M, 6-12 months). Boutique: phi = 0.50 ($100-500K, 2-4 months).

AlphaSense: manageable, not existential. $500M ARR, +73% growth. But only 2 of 10 workflow categories overlap with FDS (document search, AI research). Zero overlap in portfolio analytics, risk, trading/OMS, compliance, wealth, data feeds. Growing in greenfield (corporate, consulting), not by displacing FDS. Not mentioned in any FDS or SPGI earnings call. Zero empirical displacement evidence across 7-name peer group through H1 2026. (Cross-ticker 10-Ks/10-Qs, q=0.95.)

Could escalate to MATERIAL over 3-5 years if AlphaSense's Carousel/Financial Data integrations penetrate core workflows. The unfilled gap: we have zero product-level ASV disclosure from FDS. Aggregate retention >95% could mask product-level mix-shift. This is the highest-priority research gap.

Market share dS/dt: positive. Organic ASV accelerating, competitive displacements in banking and wealth, beneficiary of Refinitiv/LSEG post-merger disruption. TAM $10-16B (financial workstations + data infrastructure). (Transcript commentary, q=0.85.)

CUSIP regulatory risk: FDTA (2022) could mandate open identifiers. But LEI (since 2012) and FIGI have failed to gain traction in 13+ years. Industry switching costs measured in billions across clearing, settlement, trading infrastructure. Pending class action (Dinosaur Financial Group) on pricing. Assessment: 10-15% probability over 5 years, high impact if realized. (10-K risk factors, q=0.95.)

G — Governance

Overall: Adequate, with one concerning sub-dimension.

Compensation structure (well-aligned): ASV Growth + Adjusted Operating Margin metrics for annual incentives. 3-year PSUs tied to performance. CEO performance options require 50% stock appreciation to vest. 94.6% say-on-pay approval. (DEF 14A, q=0.95.)

Capital stewardship: ROIC 19.3% vs WACC 5.9% = 13.4pp value creation spread. (Derived from 10-K, q=0.90.)

Insider ownership: low. All directors and officers combined: 1.2% (439,643 shares). CEO Viswanathan: 0 shares (recently appointed). Delta_insider (open market buys minus sells, 12 months) = NEGATIVE. One director sale ($760K, Jan 2026), zero open market purchases. Company spending $600M/year on buybacks; insiders spending $0 of personal capital. (DEF 14A, Form 4 filings, q=0.95.)

Material weakness — Year 3. Disclosure controls deemed NOT effective as of Feb 28, 2026. Material weakness in IT general controls affecting program change management, monitoring, user access/segregation of duties for revenue/AR/deferred revenue systems. Adverse EY opinion on ICFR (most severe type) — but clean opinion on financial statements (no actual misstatements). Third consecutive fiscal year. Remediation: hired global head of internal audit, engaged third-party advisory, revised IT Risk and Control Matrix. Same language repeated for two years. (10-Q Q2 FY2026, q=0.95.)

Board: 90% independent, independent chair, annual elections. No activist involvement — all major holders (Vanguard, BlackRock, BAMCO, Morgan Stanley) are passive 13G filers. (DEF 14A, q=0.95.)

Beta — Factor Profile

%Idio Var ≈90% — well above the 75% target. This is a company-specific story, not a factor or sector bet. Returns are driven by FDS-specific variables (margin trajectory, displacement probability), not by market or sector factors.

Style exposures: Strong negative momentum (-49.5% 1Y). Strong value tilt (14.3x P/E, cheapest in peer group). Moderate quality (>95% retention, recurring revenue, FCF positive).

Peer intra-correlation: rho_intra approximately 0.55-0.70 during AI panic. FDS, MORN, TRI highly correlated. SPGI is the diversification outlier. Shared exposure to the proprietary-data-ai-substrate factor means these are NOT independent bets.

Two live worldview factors:

1. proprietary-data-ai-substrate [DEMAND, 365d half-life, loading 0.5]: Financial data companies are the substrate AI is built on, not disrupted by. Cross-ticker: applies to SPGI, MORN, TRI, MCO, RELX, CLVT. 7/7 peer confirmation of zero AI-driven churn.
2. fds-execution-recovery [EXECUTION, 180d half-life, loading 0.35]: Margin compression is temporary, business metrics intact. Tests at Q3 FY2026 earnings June 25.

Options positioning: ATM IV at 95.3% (167th percentile) means options are extraordinarily expensive — 1.88x realized vol. Options market is pricing extreme uncertainty that exceeds actual realized volatility by nearly 2x. P/C ratio (OI) = 0.52 (bullish near-term), shifting to 1.71 (bearish) at September expiry spanning earnings.

Delta — Expectations Gap

What the price implies

Forward P/E:       11.6x   (55-60% discount to peer avg ≈25x)
EV/EBITDA:         10.2x   (implied perpetual EBITDA growth: -3.6%)
Implied CoE:       14.2%   (6.2pp risk premium over normal, pricing AI disruption)
Implied duration:  3-5 years of above-WACC returns
FCF yield:         6.6%    (pricing zero growth beyond current FCF)

Peer comparison:

(yfinance, q=0.90.)

Three-state decomposition

Decomposing the implied probability weights by solving for the EV:

The market's dominant bet is not that FDS dies. It's that margins never recover. 84% weight on permanent erosion. Only 6% on business-as-usual recovery.

Full gap ranking by |Delta| x q

The central tension

The market isn't making one mistake. It's making two offsetting mistakes.

Mistake 1 (over-pessimistic): Pricing >50% probability of structural displacement or permanent erosion. Evidence: 7/7 peers at >90% retention, zero AI churn, ASV accelerating to 6.7%, $10B+ management buybacks across the peer group. q = 0.95 across multiple independent confirmations.

Mistake 2 (correctly pessimistic): The margin compression is real. H1 incremental margin of 0.26% (17.3% adjusted) on $79M incremental revenue validates the concern. EMEA is genuinely hemorrhaging (-75.5% incremental margin Q2). Management's own 250bps/100bps math is behind by 30bps. The market is right to worry about margins — wrong about the cause.

Same symptom (margins compressing), two diagnoses:

• Market: AI disruption causes permanent, fatal erosion
• Evidence: Investment cycle + one-times, temporary and recoverable

The alpha lives in the gap between these diagnoses. Resolution tests at Q3 FY2026 earnings June 25. If adjusted margins stabilize at 36%+, the market's diagnosis shifts. If margins compress further, the stagnation scenario gains weight.

What closes each gap

Base Rate

Base rate: Financial data/analytics companies with >$1B revenue,
           >90% recurring, and >50% price decline within 12 months
           → P(price recovery to prior peak within 24 months) ≈ 55-65%

Prior odds: 1.22:1 to 1.86:1 (55-65%)

The reference class is established, recurring-revenue data businesses that experienced severe sentiment-driven selloffs without corresponding fundamental deterioration. Historical analogs: MORN 2015-16 (post-Morningstar Direct concern, recovered), TRI 2019-20 (post-Refinitiv sale concerns, recovered), VRSK 2021-22 (post-business mix concerns, recovered). Each case featured >90% retention maintained through the selloff, followed by multiple recovery within 12-24 months.

Adjustment: FDS has a complicating factor absent from analogs — actual margin compression (-180bps adjusted) contemporaneous with the selloff. This is not purely sentiment. Shift base rate down ≈10pp to 45-55%.

Alpha vs Beta

Blended scenario EV:          +38-47% over 12-18 months
  Market beta contribution:   +5-8%    (beta 0.72 x market E[r] ≈8-10%)
  Sector contribution:        +3-5%    (financial data sector recovery from AI panic)
  Style contribution:         +5-8%    (value + negative momentum mean reversion)
  Idiosyncratic alpha:        +22-29%  <-- the actual thesis

With 90% idio variance, most of the expected return is genuinely idiosyncratic. The thesis is NOT "financial data recovers" (that's the sector/factor beta) — it's "the market's diagnosis of FDS margin compression as permanent AI disruption is wrong, and the evidence from primary sources contradicts it at q=0.95."

The factor component (sector recovery from AI panic) is shared with SPGI, MORN, TRI. The idiosyncratic component (margin inflection + CUSIP franchise undervaluation + product-level competitive position) is FDS-specific.

Steelman Bear Case

The strongest argument against this thesis is not AI displacement. It's margin stagnation without displacement.

FDS can survive — retain clients, grow ASV at 5-7%, maintain the CUSIP monopoly — and still be a bad investment if incremental margins remain near zero. Here's why this is plausible:

1. MORN does it better at the same scale. MORN has ≈$2.2B revenue, similar business model, similar AI investment cycle, and is expanding margins +210bps while FDS compresses -180bps. If the explanation is "FDS is investing for growth," then MORN is investing for growth AND expanding margins. The difference is execution, not strategy.

2. The structural drags don't self-correct. Intangible amortization growing +20% YoY ($150M annualized) won't moderate until capex/revenue stabilizes — and capex/revenue has doubled in 3 years with no sign of plateauing. EMEA's -75.5% incremental margin is driven by structural labor inflation in a 4% growth region. Cloud infrastructure costs are permanent. These aren't one-times that "roll off."

3. Insiders aren't buying. At an alleged 50%+ discount to fair value, zero insiders are spending personal capital. The company is buying back $600M/year; the people running it are buying $0. This is the dog that didn't bark.

4. Management's own productivity math doesn't work. 250bps investment - 100bps productivity = 150bps net. Actual: 180bps. The 30bps shortfall means the AI/automation productivity gains management promised are arriving slower than guided.

5. The subscription model cuts both ways. 95%+ retention means clients don't leave — but it also means clients have massive leverage on pricing. In a world where AlphaSense offers overlapping capabilities at lower cost, FDS may retain clients but at lower per-user ASV. Retention stays >95% but ASV/user declines. We can't see this in aggregate data.

Engaged honestly: Points 1 and 2 are the strongest. The MORN comparison is empirically verifiable (q=0.90) and directly undermines the "investment cycle" explanation. If MORN can invest and expand, why can't FDS? Possible answers: CUSIP integration complexity, different stage of cloud migration, higher employee intensity (12,500 vs ≈10,000 on similar revenue), recent M&A integration costs (LiquidityBook, Irwin). These are plausible explanations but not confirmed — they're hypotheses. The margin inflection at Q3/Q4 FY2026 is the test.

Point 3 (insider buying) is a genuine absence of confirming evidence, not disconfirming evidence. Insiders may be prohibited, diversifying, or simply passive. But it's notable.

Points 4 and 5 are lower-confidence concerns. Management's 30bps shortfall is within noise. Pricing pressure is hypothetical — no evidence of ASV/user decline exists.

Net assessment of bear case: The margin stagnation bear is 30% probable. Not dismissible. But it still values FDS at $280-290 (+25% from current), because margins stagnating at 35% on a growing $2.5B subscription business with a CUSIP monopoly and 6.6% FCF yield is not a terminal impairment — it's just not a re-rating catalyst.

Kill Criteria

Thesis weakened if:
- Q3 FY2026 adj op margin < 35% (H2 should benefit from one-time roll-offs)
- Organic ASV growth decelerates below 5% (breaks the acceleration narrative)
- Any peer reports dollar retention < 90% (cracks the substrate thesis)
- AlphaSense IPO at > $12B valuation (validates displacement narrative)

Thesis dies if:
- Q4 FY2026 adj op margin < 34% (structural, not temporary)
- Product-level churn disclosed or discovered (confirms hidden displacement)
- Material weakness escalates to restatement (governance failure)
- FDS raises guidance on revenue but LOWERS on margins (growth without leverage = value trap)

Thesis strengthened if:
- Q3 FY2026 adj op margin >= 36% (one-times rolling off, leverage returning)
- Organic ASV accelerates above 7% (growth narrative strengthening)
- Material weakness remediated by FY2026 10-K (governance overhang cleared)
- AlphaSense IPO at < $6B or delayed (displacement narrative weakening)

Key Risks

1. Product-level displacement hidden in aggregates (HIGH, unfilled gap). Aggregate retention >95% could mask mix-shift: losing research/search users to AlphaSense while growing in wealth and data feeds. FDS discloses revenue by geography only, not by product. This is the single biggest unknown.

2. Margin compression proves structural, not temporary (MEDIUM-HIGH). If adjusted op margins don't inflect by Q4 FY2026, the "investment cycle" explanation loses credibility. The MORN comparison is the benchmark.

3. CUSIP regulatory/litigation risk (LOW probability, HIGH impact). FDTA 2022 mandated open identifiers for government reporting. Dinosaur Financial Group class action on pricing. 10-15% probability over 5 years of material impairment.

4. $500M refinancing headwind (LOW). March 2027 maturity at 2.9% refinances to ≈5.5%. $13M/year additional interest, ≈2.3% earnings drag. Manageable but not modeled by all analysts.

5. Material weakness escalation (LOW probability, HIGH impact). Year 3. If it escalates to a restatement or SEC inquiry, the governance overhang becomes a valuation event.

What to Watch

LR Signal

LR = 1.8 (mild-to-moderate bullish)

The evidence diverges from market pricing on the displacement dimension (q=0.95, 7/7 peer confirmation) but converges on the margin dimension (q=0.95, incremental margins genuinely near zero). The market is wrong about the CAUSE of margin compression but right about the SYMPTOM. This partial confirmation limits the LR below 2.0.

If Q3 FY2026 shows margin inflection (adj >=36%), LR upgrades to 2.5-3.0. If Q3 FY2026 shows continued compression (adj <35%), LR downgrades to 1.0-1.2.

Evidence